Juneau Biosciences Overview
- Year Founded
-
2007
- Status
-
Private
- Employees
-
15
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
1
Juneau Biosciences General Information
Description
Operator of a medical genetics company intended to revolutionize the diagnosis and treatment of women's health conditions. The company develops diagnostic devices for novel gene-based diagnostics and therapeutics for endometriosis, enabling women with cures to serious and debilitating diseases.
Contact Information
Website
www.juneaubiosciences.comCorporate Office
- 1885 West 2100 South
- Suite 100
- Salt Lake City, UT 84119
- United States
Corporate Office
- 1885 West 2100 South
- Suite 100
- Salt Lake City, UT 84119
- United States
Juneau Biosciences Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 7. Debt - PPP | 28-Apr-2020 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 03-Dec-2013 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 13-Jun-2012 | Completed | Generating Revenue | |||
| 4. Early Stage VC | 01-Mar-2011 | Completed | Startup | |||
| 3. Early Stage VC | 27-Mar-2009 | Completed | Startup | |||
| 2. Early Stage VC | 25-Nov-2008 | $620K | $2.29M | Completed | Startup | |
| 1. Seed Round | 03-May-2007 | $1.67M | $1.67M | Completed | Startup |
Juneau Biosciences Patents
Juneau Biosciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20210340617-A1 | Endometriosis-associated genetic markers predict responsiveness to leuprolide acetate | Inactive | 04-Oct-2018 | ||
| EP-3861435-A1 | Endometriosis-associated genetic markers predict responsiveness to leuprolide acetate | Inactive | 04-Oct-2018 | ||
| US-20210292841-A1 | Methods of using genetic markers associated with endometriosis | Inactive | 07-Sep-2018 | ||
| EP-3847182-A1 | Methods of using genetic markers associated with endometriosis | Inactive | 07-Sep-2018 | ||
| EP-3847182-A4 | Methods of using genetic markers associated with endometriosis | Inactive | 07-Sep-2018 | C12Q1/6883 |
Juneau Biosciences Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Juneau Biosciences Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Kinect Capital | Accelerator/Incubator |
Juneau Biosciences FAQs
-
When was Juneau Biosciences founded?
Juneau Biosciences was founded in 2007.
-
Where is Juneau Biosciences headquartered?
Juneau Biosciences is headquartered in Salt Lake City, UT.
-
What is the size of Juneau Biosciences?
Juneau Biosciences has 15 total employees.
-
What industry is Juneau Biosciences in?
Juneau Biosciences’s primary industry is Diagnostic Equipment.
-
Is Juneau Biosciences a private or public company?
Juneau Biosciences is a Private company.
-
What is Juneau Biosciences’s current revenue?
The current revenue for Juneau Biosciences is .
-
How much funding has Juneau Biosciences raised over time?
Juneau Biosciences has raised $10.2M.
-
Who are Juneau Biosciences’s investors?
Kinect Capital has invested in Juneau Biosciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
